Vimta Labs Ltd Share Price

Q: What is the share price of Vimta Labs Ltd today?

Vimta Labs Ltd share price as on 22 Jan 2025 is ₹863.45

Miscellaneous - Medium / Small

NSE: VIMTALABS Small Cap ISIN: INE579C01029

As on 22 January 2025 at 18:37 IST

₹863.45

-25.70

(-2.89%)

Sell Buy

About Vimta Labs Ltd

Vimta Labs Limited is a well-known contract research and testing organisation based in India. Founded in 1984, it has been in business for decades and has a lot of experience in the field. The company provides a variety of services, including analytical testing, clinical research, preclinical studies, safety testing, method development, process validation, and environmental assessments. Its promoters have played a key role in building Vimta Labs into a trusted provider of research and testing services. Some of the main services offered include clinical research and analytical testing of some products. Read More...

Over 1 Month

-10.46%

Over 6 Months

66.24%

Over 1 Year

104.45%

Over 3 Years

116.63%

Vimta Labs Ltd Summary

Close ₹ 863.45

Open ₹ 878.70

High ₹ 878.70

Low ₹ 836.75

Volume 73,458

Net Turnover (in ₹) ₹ 17,12,56,076.40

52Wk High ₹ 1,069.95

52Wk Low ₹ 417.95

52Wk High / Low

417.95

1,069.95

Vimta Labs Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 1,975.09

EPS (TTM) 22.90

Book Value (BV) 152.18

Div. Yield 0.22 %

P/E (TTM) 41.73

Price/Book Value 5.86

Delivery % 38.72 %

Face Value 2

Key Ratios

PE Ratio 25.41

PB Ratio 3.12

EV to Sales 3.13

PEG Ratio -1.40

ROA 11.01

ROE 13

Debt-Equity 0.06

Net Profit Margin 12.40

Operating Profit Margin 28.01

Vimta Labs Ltd Financials

Profit and Loss

Consolidated

Standalone

Yearly

Quarterly

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	322.27	321.63	279.73	211.51	183.73
Total Expenses	267.79	256.64	222.82	182.97	175.46
Profit Before Tax	54.48	65	55.69	28.54	8.27
Profit After Tax	41.01	48.17	41.33	21.41	6.84
Operating Profit after Depreciation	56.60	67.64	58.41	30.71	12.04

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	171.11	174.80	168.72	134.75	137.97
Total Non Current Assets	242.45	198.67	182.84	163.82	149.91
Total Current Assets	157.60	163.66	124.36	110.54	95.86
TOTAL ASSETS	400.05	362.32	307.20	274.36	245.77
Total Shareholder's Fund	319.70	281.79	233.98	194.38	172.88

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	60.89	87.94	59.07	37.18	24.35
Net Cash used in Investing Activities	-76.05	-57.26	-37.85	-31.92	-20.84
Net Cash used in Financing Activities	-1.90	-10.98	-16.61	-4.57	-0.67

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Total Revenue	316.90	318.58	277.43	209.86	183.69
Total Expenses	265.36	254.75	220.86	181.46	175.35
Profit Before Tax	51.54	63.83	55.35	28.40	8.35
Profit After Tax	38.81	47.30	41.06	21.26	6.93
Operating Profit after Depreciation	53.65	66.47	58.07	30.56	12.11

Balance Sheet

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Fixed Assets	163.19	167.86	161.64	127.74	131.09
Total Non Current Assets	240.57	197.69	181.63	162.64	148.90
Total Current Assets	155.44	162.78	124.60	110.44	95.64
TOTAL ASSETS	396	360.47	306.23	273.07	244.53
Total Shareholder's Fund	316.29	280.58	233.65	194.32	172.96

Cash Flow

Particulars (in ₹ Cr.)	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Net Cash from Operating Activities	59.06	86.51	58.67	36.97	24.37
Net Cash used in Investing Activities	-74.60	-56.93	-37.88	-31.87	-20.09
Net Cash used in Financing Activities	-1.90	-10.66	-16.14	-4.57	-1.46

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	84.74	74.88	79.69	81.68	65.54
Total Expenses	56.61	50.57	55.27	59.84	49.91
Profit Before Tax	20.11	16.55	16.29	13.51	8.41
Profit After Tax	15.25	12.28	12.35	10.13	6.33
Operating Profit after Depreciation	28.81	25	24.91	22.74	17.67

Particulars (in ₹ Cr.)	2024-09	2024-06	2024-03	2023-12	2023-09
Total Revenue	83.14	73.32	78.34	80.10	64.39
Total Expenses	55.97	49.93	54.72	59.22	49.36
Profit Before Tax	19.22	15.69	15.55	12.60	7.86
Profit After Tax	14.59	11.64	11.80	9.46	5.92
Operating Profit after Depreciation	27.85	24.08	24.11	21.77	17.07

Vimta Labs Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3

S1 850.53

S2 811.92

S3 777.83

Pivot 884.62

R1 923.23

R2 957.32

R3 995.93

Moving Average

20 SMA 945.02

50 SMA 904.02

100 SMA 740.56

200 SMA 621.73

Vimta Labs Ltd Corporate Actions

Dividend

Bonus

Splits

Rights

AGM

EGM

Vimta Labs Ltd

₹2/Share

Announcement Date 11 Jul 2024

Record Date 12 Jul 2024

Div Yield 100%

AGM Date: 25 Jun 2022

Audited Standalone and Consolidated Financial Results for the 4th Quarter and financial year ended 31st March 2022 and Independent Auditor''s Report with unmodified opinion, along with a declaration by the Company in respect thereof. Proposed dispatch of Notice of 32nd Annual General Meeting of the Company scheduled to be held on Saturday, 25th June 2022 through Video Conference (VC) and manner of registering email addresses and bank account details. (As Per BSE Announcement dated on 14.05.2022) Intimation of date of 32nd Annual General Meeting (AGM), Book closure, Record Date and e-voting. Submission of Annual Report along with notice of Annual General Meeting (AGM) of the Company for the FY 2021-22. (As Per BSE Announcement Dated on 30/05/2022) Newspaper advertisement regarding the Notice of 32nd Annual General Meeting of the Company to be held on Saturday, 25th June 2022 at 10:00 a.m.(IST) (As Per BSE Announcement Dated on 31/05/2022) Proceedings of 32nd Annual General Meeting (AGM) held on Saturday, 25th June 2022. (As Per BSE Announcement Dated on 25.06.2022)

AGM Date: 28 Jun 2023

Audited Standalone and Consolidated Financial Results for the 4th Quarter and financial year ended 31st March 2023 and Independent Auditor''s Report. Approved the Notice of 33rd Annual General Meeting and Directors Report along with annexures. The 33th Annual General Meeting of the Company is scheduled to be held on Wednesday,28th June 2023, at 10:00 A.M. through Video Conferencing/ Other Audio Visual Means The record date and book closure dates for the purposes at the ensuing 33td Annual General Meeting is 22 June 2023 to 28th June 2023 and proposed date of payment of final dividend is 7th July 2023. Intimation of date of 33rd Annual General Meeting (AGM), Book closure, Record Date and e-voting. (As per BSE Announcement Dated on 01/06/2023) Proceedings of 33rd Annual General Meeting (AGM) held on Wednesday, 28th June 2023. (As Per BSE Announcement dated on 28.06.2023)

AGM Date: 18 Jul 2024

Approved the Notice of 34th Annual General Meeting and Directors Report along with annexures. The 34th Annual General Meeting of the Company is scheduled to be held on Thusday, 18th july 2024, at 10:00 AM. through Video Conferencing/ Other Audio-Visual mcans. Proceeding of 34th Annual General Meeting (AGM) held on Thursday, 18th July, 2024. (As Per BSE Announcement dated on 18.07.2024)

Vimta Labs Ltd Peer Comparison

Company	Price	Market Cap (in ₹ Cr)
Vimta Labs Ltd	₹892.10	₹1,981.65
Max Healthcare Institute Ltd	₹1,078.10	₹1,04,805.56
Apollo Hospitals Enterprise Ltd	₹6,918.65	₹99,479.57
Fortis Healthcare Ltd	₹639.80	₹48,302.22
Syngene International Ltd	₹832.10	₹33,495.10
Global Health Ltd	₹1,055.75	₹28,356.11

Vimta Labs Ltd News

Vimta Labs schedules board meeting

On 24 January 2025

21 Jan 2025, 10:38 am

Vimta Labs to hold board meeting

On 8 November 2024

05 Nov 2024, 01:36 pm

Vimta Labs completes sale of its diagnostic and pathological services business

11 Oct 2024, 02:29 pm

Vimta Labs to table results

On 17 July 2024

11 Jul 2024, 04:26 pm

Vimta Labs to convene AGM

On 18 July 2024

20 May 2024, 04:50 pm

Vimta Labs Ltd Stock Analysis

Annual revenue for Vimta Labs Ltd decreased by 0.53% to ₹316.90 crore in FY 2024 from ₹318.58 crore in FY 2023.
Annual Net Profit for Vimta Labs Ltd decreased by 17.95% to ₹38.81 crore in FY 2024 from ₹47.30 crore in FY 2023.
Promoter Shareholding in Vimta Labs Ltd decreased by 0.36% in the most recent quarter, from 36.89% in September 2024 to 36.76% in December 2024.
Vimta Labs Ltd delivered a 1-year return of 104.45% compared to the Nifty 50, which provided a return of 8.41% as of the last trading session.
Vimta Labs Ltd share price moved down by 2.89% from its previous close of INR ₹889.15. The latest Vimta Labs Ltd share price is INR ₹863.45.
Vimta Labs Ltd share price today has been at a low of 836.75 and a high of 878.70. Over the past 52 weeks, the Vimta Labs Ltd share price has seen a low of 417.95 and a high of 1,069.95.

About Vimta Labs Ltd

Vimta Labs Limited is a well-known contract research and testing organisation based in India. The company provides a variety of services, including analytical testing, clinical research, preclinical studies, safety testing, method development, process validation, and environmental assessments. These services support industries such as pharmaceuticals, food, agriculture, and environmental sectors.

Founded in 1984, Vimta Labs has been in business for decades and has a lot of experience in the field. Its headquarters is located in Secunderabad, Telangana. Over the years, the company has earned a reputation for delivering high-quality services. With that, it has grown its operations across multiple locations in India and even internationally.

The company is led by its promoters, including S.P. Vasireddi, who serves as the Executive Chairman, and Harita Vasireddi, the Managing Director. Here is a list of their other top managing promoters -

Harriman Vungal
Satya Sreenivas Neerukonda
Yadagiri R Pendri

They have played a key role in building Vimta Labs into a trusted provider of research and testing services. Some of the main services offered include clinical research and analytical testing of some products.

While Vimta Labs holds a solid position in India’s contract research and testing market. A notable factor is the promoter shareholding, which is at 36.89%. This reflects the confidence and dedication of the founding members toward the company’s growth and stability.

Vimta Labs' registered office and registrar are both located in Hyderabad, Telangana. The company is managed by a skilled team. Overall, Vimta Labs continues to be a trusted partner for various industries. This is thanks to their high-quality research and testing services to clients across many sectors.

History of the Company

Vimta Labs Limited has a long history as a pioneering contract research and testing organisation in India. Established in 1984 by Dr. S.P. Vasireddi, who had a strong background in analytical chemistry. The company set out with a vision to create a world-class laboratory that could offer top-notch analytical services. The company’s target industries included pharmaceuticals, food, agriculture, and environmental sectors.

In the early years, Vimta Labs concentrated mainly on analytical testing services. The company's attention to detail and adherence to international standards quickly earned it a positive reputation. This early success enabled the company to secure contracts with major pharmaceutical companies. From the start, Vimta Labs’ focus on quality and innovation made it a trusted partner for several well-known organisations.

As the demand for advanced research and testing services grew, Vimta Labs expanded its capabilities. In the 1990s, the company branched out into clinical research. They began offering new services like bioavailability and bioequivalence studies and pharmacovigilance. This expansion was fueled by the growing need for rigorous testing and validation in the pharmaceutical sector. This was very necessary, especially with the rise of generic drug manufacturing in India.

The early 2000s marked a period of significant growth and diversification for Vimta Labs. The company invested in advanced technology and established state-of-the-art facilities. These investments allowed Vimta Labs to offer an even broader range of services. It included preclinical (animal) studies, environmental assessments, and method development and validation. The ability to provide end-to-end solutions made Vimta Labs a preferred choice for clients looking for these services under one roof.

Vimta Labs has always maintained a strong commitment to quality and compliance, which has been a cornerstone of its success. Over the years, the company has earned numerous accreditations and certifications. These include ISO/IEC 17025, GLP (Good Laboratory Practice), and NABL (National Accreditation Board for Testing and Calibration Laboratories). These certifications show the company’s dedication to the highest quality standards in its services.

Vimta Labs’ success is also closely linked to its focus on organisational culture. The company places a high value on training and development. They believe in investing in their employees' continuous learning and improvement. This approach has allowed Vimta Labs to build a strong and capable workforce by attracting top talent.

Over the years, Vimta Labs has expanded its presence across India and beyond. The company has established multiple laboratories and offices. It has even formed various international collaborations and partnerships. These expansions have enabled the company to serve a wide range of clients. Having such a broad client base speaks to the company’s ability to deliver high-quality, reliable services.

Today, Vimta Labs is recognized as a leader in India’s contract research and testing industry. It continues to evolve and innovate, leveraging its decades of experience to meet the ever-changing needs of its clients. With a strong foundation built on quality and integrity, Vimta Labs is well-positioned to continue its legacy of excellence in the future.

The history of Vimta Labs showcases the vision and dedication of its founders and employees. From its modest start as a small laboratory, it has now grown into a leading provider of advanced research and testing services. The company’s journey has been marked by continuous innovation and reliable results. With its impressive track record, Vimta Labs is set to remain a trusted name in the industry for many years to come.